Dr Krishnansu Tewari is a Professor and Director of Research in the Division of Gynecologic Oncology at the University of California, Irvine, USA.
His clinical interests include cytoreductive surgeries and advanced gynecologic (including robotic) surgery, ovarian carcinoma and other gynecologic cancers, and fallopian tube and primary peritoneal cancers. His past research led to approval of bevacizumab for advanced cervical cancer and he continues to investigate novel targeted therapeutics in ovarian cancer and cervical cancer.
Dr Tewari has published over 130 peer reviewed articles and written numerous book chapters. He serves as the Principal Investigator of the NCI’s NRG-Oncology Cooperative Group and is on the Society of Gynecologic Oncology Publications Committee.
He has been listed in Best Doctors of America numerous times.